Bjørn Grønberg 37th TROG Cancer Research Annual Scientific Meeting 2025

Abstracts this author is presenting:

• Durvalumab after high-dose twice-daily thoracic radiotherapy in limited stage small cell lung cancer. DAHRTS – a randomized phase III trial — Session 9: Lung Tumour Stream